88 related articles for article (PubMed ID: 23006045)
1. A positive event dependence model for self-controlled case series with applications in postmarketing surveillance.
Simpson SE
Biometrics; 2013 Mar; 69(1):128-36. PubMed ID: 23006045
[TBL] [Abstract][Full Text] [Related]
2. Multiple self-controlled case series for large-scale longitudinal observational databases.
Simpson SE; Madigan D; Zorych I; Schuemie MJ; Ryan PB; Suchard MA
Biometrics; 2013 Dec; 69(4):893-902. PubMed ID: 24117144
[TBL] [Abstract][Full Text] [Related]
3. A conditional sequential sampling procedure for drug safety surveillance.
Li L
Stat Med; 2009 Nov; 28(25):3124-38. PubMed ID: 19691034
[TBL] [Abstract][Full Text] [Related]
4. Early detection of adverse drug events within population-based health networks: application of sequential testing methods.
Brown JS; Kulldorff M; Chan KA; Davis RL; Graham D; Pettus PT; Andrade SE; Raebel MA; Herrinton L; Roblin D; Boudreau D; Smith D; Gurwitz JH; Gunter MJ; Platt R
Pharmacoepidemiol Drug Saf; 2007 Dec; 16(12):1275-84. PubMed ID: 17955500
[TBL] [Abstract][Full Text] [Related]
5. Observational studies and the withdrawal of rofecoxib.
Watson DJ; Santanello NC
Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):199-201; author reply 203-5. PubMed ID: 16508998
[No Abstract] [Full Text] [Related]
6. A simulation study to compare three self-controlled case series approaches: correction for violation of assumption and evaluation of bias.
Hua W; Sun G; Dodd CN; Romio SA; Whitaker HJ; Izurieta HS; Black S; Sturkenboom MC; Davis RL; Deceuninck G; Andrews NJ
Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):819-25. PubMed ID: 23625875
[TBL] [Abstract][Full Text] [Related]
7. When should case-only designs be used for safety monitoring of medical products?
Maclure M; Fireman B; Nelson JC; Hua W; Shoaibi A; Paredes A; Madigan D
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():50-61. PubMed ID: 22262593
[TBL] [Abstract][Full Text] [Related]
8. Bias correction of risk estimates in vaccine safety studies with rare adverse events using a self-controlled case series design.
Zeng C; Newcomer SR; Glanz JM; Shoup JA; Daley MF; Hambidge SJ; Xu S
Am J Epidemiol; 2013 Dec; 178(12):1750-9. PubMed ID: 24327463
[TBL] [Abstract][Full Text] [Related]
9. Estimation and reduction of bias in self-controlled case series with non-rare event dependent outcomes and heterogeneous populations.
Lee KM; Cheung YB
Stat Med; 2024 May; 43(10):1955-1972. PubMed ID: 38438267
[TBL] [Abstract][Full Text] [Related]
10. Safety of gadobutrol, a new generation of contrast agents: experience from clinical trials and postmarketing surveillance.
Voth M; Rosenberg M; Breuer J
Invest Radiol; 2011 Nov; 46(11):663-71. PubMed ID: 21623211
[TBL] [Abstract][Full Text] [Related]
11. COX-2 inhibitor use after Vioxx: careful balance or end of the rope?
Fendrick AM
Am J Manag Care; 2004 Nov; 10(11 Pt 1):740-1. PubMed ID: 15623263
[No Abstract] [Full Text] [Related]
12. The Vioxx fallout.
Palmer K
Minn Med; 2005 Mar; 88(3):26-30. PubMed ID: 15852592
[No Abstract] [Full Text] [Related]
13. A modified self-controlled case series method to examine association between multidose vaccinations and death.
Kuhnert R; Hecker H; Poethko-Müller C; Schlaud M; Vennemann M; Whitaker HJ; Farrington CP
Stat Med; 2011 Mar; 30(6):666-77. PubMed ID: 21337361
[TBL] [Abstract][Full Text] [Related]
14. Evaluating drug effects in the post-Vioxx world: there must be a better way.
Avorn J
Circulation; 2006 May; 113(18):2173-6. PubMed ID: 16684873
[No Abstract] [Full Text] [Related]
15. How to avoid another 'Vioxx'.
Frantz S
Nat Rev Drug Discov; 2005 Jan; 4(1):5-7. PubMed ID: 15690595
[No Abstract] [Full Text] [Related]
16. Postmarketing surveillance of serious adverse events associated with the use of rofecoxib from 1999-2002.
Bottone FG; Barry WT
Curr Med Res Opin; 2009 Jun; 25(6):1535-50. PubMed ID: 19453292
[TBL] [Abstract][Full Text] [Related]
17. [Cardiovascular risk: a class effect of coxibs? How to manage patients taking Vioxx?].
Brune K; Zacher J
MMW Fortschr Med; 2004 Oct; 146(42):10, 12. PubMed ID: 15536697
[No Abstract] [Full Text] [Related]
18. Fractional polynomial adjustment for time-varying covariates in a self-controlled case series analysis.
Lee KJ; Carlin JB
Stat Med; 2014 Jan; 33(1):105-16. PubMed ID: 23868284
[TBL] [Abstract][Full Text] [Related]
19. Lessons on prescribing and drug safety from the withdrawal of rofecoxib.
Nelson M; Cicuttini F
Aust Fam Physician; 2004 Dec; 33(12):965-6. PubMed ID: 15630913
[No Abstract] [Full Text] [Related]
20. Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study.
Rahme E; Watson DJ; Kong SX; Toubouti Y; LeLorier J
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):493-503. PubMed ID: 17086567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
